Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

References for PMC Articles for PubMed (Select 1520589)

1.

Significance of occult metastases. A study of breast cancer.

PICKREN JW.

Cancer. 1961 Nov-Dec;14:1266-71. No abstract available.

PMID:
14486400
2.

Predictors of recurrence in stage I (T1N0M0) breast carcinoma.

Rosen PP, Saigo PE, Braun DW Jr, Weathers E, DePalo A.

Ann Surg. 1981 Jan;193(1):15-25.

3.

Axillary micro- and macrometastases in breast cancer: prognostic significance of tumor size.

Rosen PP, Saigo PE, Braun DW, Weathers E, Fracchia AA, Kinne DW.

Ann Surg. 1981 Nov;194(5):585-91.

4.

[Axillary lymph nodes in breast cancer. Comparison of standard histological analytical technics and macroscopic serial sections].

de Mascarel I, Trojani M, Abadjian G, Durand M, Bonichon F, Coindre JM, Meuge-Moraw C.

Bull Cancer. 1982;69(5):451-5. French.

PMID:
6762234
5.

The immunocytochemical detection of axillary micrometastases in breast cancer.

Wells CA, Heryet A, Brochier J, Gatter KC, Mason DY.

Br J Cancer. 1984 Aug;50(2):193-7.

6.

Significance of axillary macrometastases and micrometastases in mammary cancer.

Huvos AG, Hutter RV, Berg JW.

Ann Surg. 1971 Jan;173(1):44-6. No abstract available.

7.

The immunohistochemical detection of lymph node metastases from infiltrating lobular carcinoma of the breast.

Bussolati G, Gugliotta P, Morra I, Pietribiasi F, Berardengo E.

Br J Cancer. 1986 Oct;54(4):631-6.

8.

Micrometastases to axillary lymph nodes from invasive lobular carcinoma of breast: detection by immunohistochemistry and prognostic significance.

Trojani M, de Mascarel I, Coindre JM, Bonichon F.

Br J Cancer. 1987 Dec;56(6):838-9. No abstract available.

9.

The use of monoclonal antibodies for the histopathological detection of mammary axillary micrometastases.

Byrne J, Waldron R, McAvinchey D, Dervan P.

Eur J Surg Oncol. 1987 Oct;13(5):409-11.

PMID:
3311817
10.

Importance of tumor cells in axillary node sinus margins ('clandestine' metastases) discovered by serial sectioning in operable breast carcinoma.

Friedman S, Bertin F, Mouriesse H, Benchabat A, Genin J, Sarrazin D, Contesso G.

Acta Oncol. 1988;27(5):483-7.

PMID:
3060155
11.
12.
13.

Prognostic significance of cytokeratin-positive breast cancer metastases.

Sedmak DD, Meineke TA, Knechtges DS, Anderson J.

Mod Pathol. 1989 Sep;2(5):516-20.

PMID:
2479008
15.

Are breast cancer axillary node micrometastases worth detecting?

Neville AM.

J Pathol. 1990 Aug;161(4):283-4. Review. No abstract available.

PMID:
2213369
16.

How to use prognostic factors in axillary node-negative breast cancer patients.

McGuire WL, Tandon AK, Allred DC, Chamness GC, Clark GM.

J Natl Cancer Inst. 1990 Jun 20;82(12):1006-15. Review. No abstract available.

PMID:
2189998
17.

Detection and significance of occult axillary node metastases in patients with invasive breast cancer.

Fisher ER, Swamidoss S, Lee CH, Rockette H, Redmond C, Fisher B.

Cancer. 1978 Oct;42(4):2025-31.

PMID:
213191
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk